Abstract P1-09-26: Genomic analysis of circulating tumor DNA (ctDNA) from patients with triple-negative, HER2-mutant metastatic breast cancer treated with neratinib as monotherapy or in combination with trastuzumab in the SUMMIT trial
- Komal Jhaveri
- , James Waisman
- , Sara A. Hurvitz
- , Adam Brufsky
- , Cynthia Ma
- , Maria de Miguel
- , Ella Evron
- , Nisha Unni
- , Olivier Tredan
- , Devalingam Malingham
- , Pavitra Rao
- , Karthigayini Sivaprakasam
- , Ronak Shah
- , Eric Buehler
- , Karmelina Charalambous
- , Georg F. Bischof
- , Daniel DiPrimeo
- , Lisa D. Eli
- , David Solit
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.